| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 689.29 KB | Adobe PDF |
Orientador(es)
Resumo(s)
The use of aspirin in primary prevention (PP) remains a matter of international debate. In type 2 diabetes mellitus (DM2) patients with high/very high cardiovascular (CV) risk, low dose aspirin may be considered for PP (class IIb, evidence level A) in european guidelines in the absence of hemorrhagic contraindication.
Descrição
Palavras-chave
Contexto Educativo
Citação
Editora
Oxford University Press
